News

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV administration.Significant tumor reduction was observed in both administration routes. Both IT and IV were ...
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of patients with cutaneous ...
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and ...
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancerPatient recruitment ...
Leap Therapeutics to Present Preclinical Data of FL-501, a Novel GDF-15 Neutralizing Antibody, at the AACR 2025 Annual Meeting
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present preclinical data of FL-501 in a poster ...
Avvio Medical to Present Clinical Trial Results at the 2025 American Urological Association Annual Meeting
Avvio Medical Inc. (formerly Applaud Medical, Inc.) today announced that results from its AEROLITH randomized clinical trial ...
Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting
Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting ...
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
Presentation will take place during the “Developmental Therapeutics - Immunotherapy” session on May 31, 2025, from 3:00 – 6:00pm CT at McCormick Place, ChicagoFORT LAUDERDALE, Fla. and WEST DES MOINES ...
Q1 2025 First Merchants Corp Earnings Call
Michele Kawiecki; Chief Financial Officer, Executive Vice President; First Merchants Corp John Martin; Executive Vice President, Chief Credit Officer; First Merchants Corp Thank you for standing by ...
Q1 2025 Matador Resources Co Earnings Call
Brian Willey; Chief Financial Officer, Executive Vice President, President - Midstream Operations; Matador Resources Co Good morning, ladies and gentlemen. Welcome to the first-quarter 2025 Matador ...
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society
Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...
Semperis' Guido Grillenmeier to Unpack the Microsoft Cloud Identity Crisis at RSAC 2025 Conference
Semperis, a leader in AI-powered identity security and cyber resilience, today announced that Guido Grillenmeier, Principal Technologist, EMEA, will be speaking at the RSAC 2025 Conference on The ...